Ductal carcinoma in situ: USC/Van Nuys Prognostic Index and the impact of margins status

Breast

Volumn 12, Issue 6, 2003, Pages 457-471

  Silverstein, Melvin J ^a   Buchanan, Claire ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

DCIS; Ductal carcinoma in situ; In situ breast cancer; Margin width; Non invasive breast cancer; USC Van Nuys Prognostic Index

Indexed keywords

PLACEBO; TAMOXIFEN;

ALGORITHM; BREAST DUCT; CANCER CENTER; CANCER SURVIVAL; CANCER TISSUE; CARCINOMA IN SITU; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; DATA BASE; EXCISION; HISTOPATHOLOGY; HUMAN; MASTECTOMY; MEDICAL DECISION MAKING; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SCORING SYSTEM; TREATMENT PLANNING; TUMOR CLASSIFICATION; TUMOR NECROSIS; TUMOR RECURRENCE; TUMOR VOLUME; UNITED STATES;

EID: 0346258222     PISSN: 09609776     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-9776(03)00153-X     Document Type: Article

References (56)

1. Patchesfsky A S, Schwartz G F, Finkelstein S D et al. Heterogeneity of intraductal carcinoma of the breast. Cancer 1989; 63: 731-741.
2. Lennington W J, Jensen R A, Dalton L W et al. Ductal carcinoma in situ of the breast. Heterogeneity of individual lesions. Cancer 1994; 73: 118-124.
3. Silverstein M J. Intraductal breast carcinoma: two decades of progress? Am J Clin Oncol 1991; 14: 534-537.
4. Fisher B, Constantino J, Redmond C et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med 1993; 328: 1581-1586.
5. Fisher E R, Constantino J, Fisher B et al. Pathologic finding from the National Surgical Adjuvant Breast and Bowel Project (NSABP) protocol B-17: intraductal carcinoma (ductal carcinoma in situ). Cancer 1995; 75: 1310-1319.
6. Fisher B, Dignam J, Wolmark N et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from National Surgical Adjuvant Breast and Bowel Project B-17. J Clin Oncol 1998; 16: 441-452.
7. Fisher E R, Dingnam J, Tan-Chiu E et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) eight year update of protocol B- 17: intraductal carcinoma. Cancer 1999; 86: 429-438.
8. Fisher B, Land S, Mamounas E et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the National Surgical Adjuvant Breast Project experience. Semin Oncol 2001; 28: 400-418.
9. Fisher B, Dignam J, Wolmark N. Tamoxifen in the treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomized controlled trial. Lancet 1999; 353: 1993-2000.
10. Julien J P, Bijker N, Fentiman I et al. Radiotherapy in breast conserving treatment for ductal carcinoma in situ: first results of EORTC randomized phase III trial 10853. Lancet 2000; 355: 528-533.
11. Bijker N, Peterse J L, Duchateau L et al. Risk factors for recurrence and metastasis after breast conserving therapy for ductal carcinoma in situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol 2001; 19: 2263-2271.
12. George W D, Houghton J, Cuzick J et al. Radiotherapy and tamoxifen following complete local excision (CLE) in the management of ductal carcinoma in situ (DCIS): preliminary results from the UK DCIS trial. Proc Am Soc Clin Oncol 2000; 19: 70a(abst).
13. UK Coordinating Committee on Cancer Research (UKCCCR), Ductal Carcinoma in situ (DCIS), Working Party on behalf of the DCIS Trialists in the UK, Australia, and New Zealand. Radiotherapy and tamoxifen in women with completely excised ductal carcinoma in situ of the breast in the UK, Australia, and New Zealand: randomized controlled trial. Lancet 2003; 362: 95-102.
14. Silverstein M J. The Van Nuys Breast Center-The first free-standing multidisciplinary breast center. Surg Oncol Clin North Am 2000; 9(2): 159-175.
15. Recht A. Side effects of radiation therapy. In: Silverstein M J, ed. Ductal Carcinoma In Situ of the Breast. Baltimore: Williams and Wilkins, 1997; 347-352.
16. Silverstein M J, Barth A, Poller D N et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer 1995; 31: 1425-1427.
17. Silverstein M J, Poller D N, Waisman J R et al. Prognostic classification of breast duct carcinoma in situ. Lancet 1995; 345: 1154-1157.
18. Lagios M D, Margolin F R, Westdahl P R et al. Mammographically detected duct carcinoma in situ. Frequency of local reccurrence following tylectomy and prognostic effect of nuclear grade on local recurrence. Cancer 1989; 63: 618-624.
19. Schwartz G. The role of exicision and surveillance alone in subclinical DCIS of the breast. Oncology 1994; 8(2): 21-26.
20. Solin L, Yeh I, Kurtz J et al. Ductal carcinoma in situ (intraductal carcinoma) of the breast treated with breast conserving surgery and definitive irradiation. Correlation of pathologic parameters with outcome of treatment. Cancer 1993; 71: 2532-2542.
21. Lagios M D, Westdahl P R, Margolin F R et al. Duct carcinoma in situ: relationship of extent of noninvasive disease to the frequency of occult invasion, multicentricity, lymph node metastases, and short-term treatment failures. Cancer 1982; 50: 1309-1314.
22. Poller D, Silverstein M J, Galea M et al. Ductal carcinoma in situ of the breast: a proposal for a new simplified histologic classification association between cellular proliferation and c-erbB-2 protein expression. Modern Pathol 1994; 7: 257-262.
23. Bellamy C, McDonald C, Salter D et al. Noninvasive ductal carcinoma of the breast: the relevance of histologic categorization. Hum Pathol 1993; 24: 16-23.
24. Lagios M D. Ductal carcinoma in situ: controversies in diagnosis, biology, and treatment. Breast J 1995; 1: 68-78.
25. Ottesen G L, Graversen H P, Blichert-Toft M et al. Ductal carcinoma in situ of the female breast. Short term results of a prospective nationwide study. Am J Surg Pathol 1992; 16: 1183-1196.
26. Zafrani B, Leroyer A, Fourquet A et al. Mammographically detected ductal carcinoma in situ of the breast analyzed with a new classification. A study of 127 cases: correlation with estrogen and progesterone receptors, p53 and c-erb-2 proteins, and proliferation activity. Semin Diagn Pathol 1994; 11(3): 208-213.
27. Silverstein M J, Lagios M D, Craig P H et al. A prognostic index for ductal carcinoma in situ. Cancer 1996; 77: 2267-2274.
28. Silverstein M, Lagios M, Craig P et al. The Van Nuys Prognostic Index for ductal carcinoma in situ. Breast J 1996; 2: 38-40.
29. Silverstein M J. The University of Southern California/Van Nuys Prognostic Index. In: Silverstein M J, ed. Ductal Carcinoma In Situ of the Breast, 2nd Edition. Philadelphia: Williams and Wilkins, 2002; 459-473.
30. Galea M, Blamey R, Elston C et al. The Nottingham Prognostic Index in primary breast cancer. Breast Cancer Res Treat 1992; 22: 207-219.
31. Silverstein M J. Van Nuys Prognostic Index for DCIS. In: Silverstein M J, ed. Ductal Carcinoma In Situ of the Breast. Baltimore: Williams and Wilkins, 1997; 491-504.
32. Solin L J, Kurtz J, Fourquet A et al. Fifteen year results of breast conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol 1996; 14: 754-763.
33. Vicini F A, Kestin L L, Goldstein N S et al. Impact of young age on outcome in patients with ductal carcinoma-in-situ treated with breast conserving therapy. J Clin Oncol 2000; 18: 296-306.
34. Szelei-Stevens K A, Kuske R, Yantos V A et al. The influence of young age and positive family history of breast cancer on the prognosis of ductal carcinoma in situ treated with excision with or without radiation therapy or mastectomy. Int J Radiat Oncol Biol Phys 2000; 48: 943-949.
35. Goldstein N S, Vicini F A, Kerstin L L et al. Differences in the pathologic features of ductal carcinoma in situ of the breast based on patient age. Cancer 2000; 88: 2552-2560.
36. Silverstein M J, Gierson E D, Colburn W J et al. Can intraductal breast carcinoma be excised completely by local excision? Cancer 1994; 73: 2985-2989.
37. Solin L J, Fourquet A, Vicini F A et al. Mammographically directed ductal carcinoma in situ of the breast treated with breast conserving surgery and definitive breast irradiation: long-term outcome and prognostic significance of patient age and margin status. Int J Radiat Oncol Biol Phys 2001; 50: 991-1002.
38. Silverstein M J, Lagios M D, Martino S et al. Outcome after local recurrence in patients with ductal carcinoma in situ of the breast. J Clin Oncol 1998; 16: 1367-1373.
39. Ashikari R, Hadju S I, Robbins G F. Intraductal carcinoma of the breast. Cancer 1971; 28: 1182-1187.
40. Fentiman I S, Fagg N, Mills R R et al. In situ ductal carcinoma of the breast: implications of disease pattern and treatment. Eur J Surg Oncol 1986; 12: 261-266.
41. Bradley S J, Weaver D W, Bouwman D L. Alternative in the surgical management of in situ breast cancer. Am Surg 1990; 56: 428-432.
42. Rosner D, Bedwani R N, Vana J et al. Noninvasive breast carcinoma. Results of a national survey of the American College of Surgeons. Ann Surg 1980; 192: 139-147.
43. Lagios M D. Duct carcinoma in situ: pathology and treatment. Surg Clin North Am 1990; 70: 853-871.
44. Schwartz G F, Finkel G C, Garcia J C et al. Subclinical ductal carcinoma in situ of the breast. Treatment by local excision and surveillance alone. Cancer 1992; 70: 2468-2474.
45. Solin L J, Recht A, Fourquet A et al. Ten-year results of breast-conserving surgery and definitive irradiation for intraductal carcinoma of the breast. Cancer 1991; 68: 2337-2344.
46. McCormick B, Rosen P P, Kinne D et al. Duct carcinoma in situ of the breast: an analysis of local control after conservation surgery and radiotherapy. Int J Radiat Oncol Biol Phys 1991; 21: 289-292.
47. Bornstein B A, Recht A, Connolly J L et al. Results of treating ductal carcinoma in situ of the breast with conservative surgery and radiation therapy. Cancer 1991; 67: 7-13.
48. Schnitt S J, Harris J R, Smith B L. Developing a prognostic index for ductal carcinoma in situ of the breast: are we there yet? Cancer 1996; 77: 2189-2192.
49. Rosai J. Borderline epithelial lesions of the breast. Am J Surg Pathol 1991; 15: 209-221.
50. Schnitt S J, Connolly J L, Tavassoli F A et al. Interobserver reproducibility in the diagnosis of ductal proliferative breast lesions using standardized criteria. Am J Surg Pathol 1992; 16: 33-43.
51. Faverly D R G, Burgers L, Bult P et al. Three dimensional imaging of mammary ductal carcinoma in situ; clinical implications. Semin Diagn Pathol 1994; 11: 193-198.
52. Holland R, Hendriks J H C L, Verbeek A L M et al. Extent, distribution and mammographic/histologic correlations of breast ductal carcinoma in situ. Lancet 1990; 335: 519-522.
53. Holland R, Faverly D R G. Local distribution of ductal carcinoma in situ of the breast: whole organ studies. In: Silverstein M J, ed. Ductal Carcinoma In Situ of the Breast, 2nd Edition. Philadelphia: Lippincott, Williams and Wilkins, 2002; 240-248.
54. Silverstein M J, Lagios M D. Ductal carcinoma in situ: factors predicting recurrence and how they can be used in treatment planning. Oncology 1997; 11(3): 393-410.
55. Lagios M D, Silverstein M J. Duct carcinoma in situ: the success of breast conservation therapy: a shared experience of two single institution nonrandomized prospective studies. Surg Oncol Clin North Am 1997; 6(2): 385-392.
56. Sibbering D M, Blamey R W. Nottingham experience. In: Silverstein M J, ed. Ductal Carcinoma In Situ of the Breast. Baltimore: Williams and Wilkins, 1997; 271-284.